Elevate Your Expertise in Aplastic Anemia (AA)
A Dynamic e-Learning Series!
Take your knowledge and confidence to the next level with our engaging, interactive e-Learning program on diagnosing and treating AA. Guided
by
Regis Peffault de Latour,
Morag Griffin and
Austin Kulasekararaj, this 3-module series delivers cutting edge insights paired with real-world case studies.
WHAT
YOU'LL
LEARN
WHY TIMING MATTERS
Master the critical steps required for early diagnosis and referral to specialized centers of care
TREATMENT EXCELLENCE
Explore the benefits and risks of current AA therapies to optimize outcomes for your patients
ADVANCED PATIENT MANAGEMENT
Develop tailored approaches for special subgroups and tackle complex clinical scenarios with confidence
Don’t miss this opportunity to enhance your skills and make a lasting impact on your patients’ lives.
Sign up now and transform the way you care for your patients with AA.
By registering for this program, you will also gain free access to our sister medical education platform, Springer Medicine. Providing you with our latest CME content, articles from more than 500 Springer journals, and breaking news in your therapy area, Springer Medicine helps keep your patient care effortlessly up to date.
Learning
Objectives
After completing these modules participants will be able to:
Meet
the
experts
Program Director
Prof. Régis Peffault de Latour
Head, French reference Center for Aplastic Anemia, Paris, France
Prof Peffault de Latour is currently the head of the Hematology and Bone
Marrow Transplant Department, Hôpital Saint-Louis, Paris, France since
2022.
He is also responsible for the French Reference Center for Aplastic Anemia and PNH, as well as the French healthcare network for rare immuno-hematological diseases (MaRIH). He is the chair of the Severe Aplastic Anemia Working Party (SAAWP) of the European Blood and Marrow Transplantation (EMBT) group.
Read More
Disclosures:
Consulting/speaker (symposium): Alexion, Apellis, Novartis, Pfizer. Research grant: MSD, Novartis, Pfizer.
Dr Morag Griffin
Consultant in Hematology, St James’s University Hospital, Leeds, UK
Dr. Morag Griffin is a joint clinical lead of the aplastic anemia and PNH service in Leeds (UK). She is also a clinical adviser to the Aplastic Anaemia Trust (UK) and a Member of the International PNH Interest Group (IPIG) and Severe Aplastic Anemia Working Party (SAAWP).
Read More
Disclosures:
Consulting/Speaker (symposium): Alexion, Novartis, Omeros, Pfizer,
Regeneron, Sobi
Dr Austin Kulasekararaj
Consultant Hematologist, Kings College Hospital, London, UK
Dr. Austin Kulasekararaj is a consultant hematologist at King’s College Hospital (UK), specializing in aplastic anaemia, bone marrow failure syndromes, PNH, MDS, and myeloid malignancies.
He is the lead of the King’s National PNH service and the national AA referral centre at King’s College Hospital (UK).
He is the lead of the King’s National PNH service and the national AA referral centre at King’s College Hospital (UK).
Read More
Disclosures:
Consulting/speaker (symposium/bureau): Alexion/AstraZeneca, Amgen,
Celgene/BMS, Pfizer, Novartis, Ra Pharma/UCB, Roche, SOBI, Janssen,
Apellis, Agios, Biocryst, Geron, Regeneron
Grants/research support: Celgene/BMS and Novartis
Grants/research support: Celgene/BMS and Novartis
